Showing results (2121-2130 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|December 13, 2016
Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantationB Kornblit, K MüllerBone Marrow Transplantation|December 13, 2016
Low-dose alemtuzumab for GvHD prevention followed by prophylactic donor lymphocyte infusions in high-risk leukemiaP Tsirigotis, M Liga, K Gkirkas, et al.Bone Marrow Transplantation|October 25, 2016
Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?P Dhakal, V R BhattBone Marrow Transplantation|November 8, 2016
Pregnancy outcome following hematopoietic cell transplantation for thalassemia majorS Santarone, A Natale, P Olioso, et al.Bone Marrow Transplantation|February 21, 2019
Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agentsShohei Mizuno, Koji Kawamura, Ichiro Hanamura, et al.Bone Marrow Transplantation|February 21, 2019
Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumorsJane Koo, Stacy Silverman, Brandon Nuechterlein, et al.Bone Marrow Transplantation|February 28, 2019
Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.Bone Marrow Transplantation|February 28, 2019
Effects of smoking on outcomes of hematopoietic cell transplantation: a systemic review and future directionsMohammed Abufarhaneh, Shawna L Ehlers, Linda J Burns, et al.Bone Marrow Transplantation|March 28, 2017
Evolving concepts in prognostic scoring of chronic GvHDA Lazaryan, M AroraBone Marrow Transplantation|March 6, 2019
The role of checkpoint blockade after allogeneic stem cell transplantation in diseases other than Hodgkin's LymphomaTobias A W Holderried, Alessia Fraccaroli, Martin Schumacher, et al.Pageof 993